Alcohol, Drugs and Addictive Behaviours
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.

Screening and brief intervention for alcohol problems in primary health care

 

BACKGROUND

There are many forms of excessive drinking that cause substantial risk or harm to the individual. They include high level drinking each day, repeated episodes of drinking to intoxication, drinking that is actually causing physical or mental harm, and drinking that has resulted in the person becoming dependent on alcohol. Excessive drinking causes illness and distress to the drinker and his or her family and friends. It is a major cause of breakdown in relationships, trauma, hospitalization, prolonged disability and early death. Alcohol-related problems represent an immense economic loss to many communities around the world. 

 

Screening for alcohol use: why AUDIT?

The AUDIT was developed as a simple method of screening for excessive drinking and to assist in brief assessment. It can help identify excessive drinking as the cause of the presenting illness. It provides a framework for intervention to help risky drinkers reduce or cease alcohol consumption and thereby avoid the harmful consequences of their drinking. The AUDIT also helps to identify alcohol dependence and some specific consequences of harmful drinking. Of utmost importance for screening is the fact that people who are not dependent on alcohol may stop or reduce their alcohol consumption with appropriate assistance and effort. The manual is particularly designed for health care practitioners and a range of health settings, but with suitable instructions it can be self-administered or used by non-health professionals. 

Screening for alcohol consumption among patients in primary care carries many potential benefits. It provides an opportunity to educate patients about low-risk consumption levels and the risks of excessive alcohol use. Information about the amount and frequency of alcohol consumption may inform the diagnosis of the patient's presenting condition, and it may alert clinicians to the need to advise patients whose alcohol consumption might adversely affect their use of medications and other aspects of their treatment. Screening also offers the opportunity for practitioners to take preventative measures that have proven effective in reducing alcohol-related risks. 

Development and validation of the AUDIT

The AUDIT was developed and evaluated over a period of two decades, and it has been found to provide an accurate measure of risk across gender, age and cultures. As the first screening test designed specifically for use in primary care settings, the AUDIT has the following advantages:

  • Cross-national standardization: the AUDIT was validated on primary health care patients in six countries. It is the only screening test specifically designed for international use;
  • Identifies hazardous and harmful alcohol use, as well as possible dependence;
  • Brief, rapid and flexible;
  • Designed for primary health care workers;
  • Consistent with ICD-10 definitions of alcohol dependence and harmful alcohol use;
  • Focuses on recent alcohol use.

BRIEF INTERVENTION

Brief interventions are those practices that aim to identify a real or potential alcohol problem and motivate an individual to do something about it. Brief interventions have become increasingly valuable in the management of individuals with alcohol-related problems. During the past 20 years, there have been numerous randomized trials of brief interventions in a variety of health care settings. Studies have been conducted in Australia, Bulgaria, Mexico, the United Kingdom, Norway, Sweden, the United States and many other countries. Results from these studies show that there is clear evidence that well-designed brief intervention strategies are effective, low-cost and easy to administer.

Because research has shown that brief interventions are low in cost and have proven to be effective across the spectrum of alcohol problems, health workers and policy-makers have increasingly focused on them as tools to fill the gap between the primary prevention efforts and more intensive treatment for persons with serious alcohol use disorders. It is worth noting that brief interventions are not designed to treat persons with alcohol dependence, which generally requires greater expertise and more intensive clinical management. However, they might serve well as as initial treatment for severely dependent patients seeking extended treatment.

Alongside with the companion publication on the AUDIT, WHO has also produced a manual to aid primary health care workers in administering brief interventions to persons whose alcohol consumption has become hazardous or harmful to their health. Together, these manuals describe a comprehensive approach to alcohol screening and brief intervention (SBI) that is designed to improve the health of the population and patient groups as well as individuals. 

 

Related activities:

The ASSIST project - Alcohol, Smoking and Substance Involvement Screening Test

 

 

Publications

This manual introduces the AUDIT, the Alcohol Use Disorders Identification Test, and describes how to use it to identify persons with hazardous and harmful...

Key ingested per- and poly-fluoroalkyl substances (PFAS) and their health effects: landscape review

The World Health Organization (WHO) commissioned a landscape review to systematically collect and assess available data sources on PFAS occurrence and...

Safety evaluation of certain contaminants in food: prepared by the one hundred and first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA)

This monograph presents the safety evaluation of arsenic as a contaminant in food conducted by the Joint FAO/WHO Expert Committee on Food Additives (JECFA)...

Seven strategies to prevent drowning: technical package for policy-makers

Each year, drowning claims more than 300 000 lives globally. Although the vast majority of drowning deaths are preventable, many countries lack the policies,...

Consolidated HIV guidelines: service delivery

HIV remains a major public health challenge, especially in low- and middle-income countries. Inconsistent or delayed implementation of evidence-based...

WHO Global Traditional Medicine Centre: Annual Report 2025

In 2025, World Health Organization (WHO) leadership reaffirmed Traditional Medicine as a strategic priority within the Organization’s broader transformation...

Formative evaluation of the Global Health Cluster: Web annexes

The evaluation served a dual purpose of accountability and learning designed to generate forward-looking recommendations for improving WHO's humanitarian...

WHO Drug Information - Volume 40, No. 2

The second issue of volume 40 for 2026 includes:- Evidence-to-Decision Framework to Prioritize PD-1 and PD-L1 Immune Checkpoint Inhibitors for the WHO...

Target product profile – developing in vitro diagnostics for low- and middle-income settings

This target product profile provides a comprehensive set of generic characteristics to guide the development or adaptation of in vitro diagnostics (IVDs)...

Eleventh Meeting of the WHO South-East Asia Regional Verification Commission for Measles and Rubella Elimination

The documents provides the details of the proceedings, conclusions and recommendations of the eleventh meeting of the WHO South-East Asia Regional Verification...

Risk reduction of cognitive decline and dementia: WHO guidelines, second edition

This publication provides updated evidence-based recommendations on interventions to reduce the risk of cognitive decline and dementia. The guidelines...

Root cause analysis of low yellow fever vaccination coverage: user manual and questionnaire

The Root cause analysis of low yellow fever vaccination coverage tool focuses on districts with insufficient routine immunization coverage. It includes...

WHO target product profile for Bundibugyo virus disease vaccines, 14 July 2026

Bundibugyo virus disease, which is caused by Bundibugyo virus, is a severe filovirus infection with epidemic potential that requires the development of...

Guideline on doxycycline post-exposure prophylaxis for sexually transmitted infections among men who have sex with men and transgender women

This guideline provides evidence-informed recommendations on the use of doxycycline post-exposure prophylaxis (PEP) for the prevention of bacterial sexually...

The Diagnostic testing for Ebola disease and Marburg virus disease: interim guidance, 9 July 2026

Rapid diagnosis of Ebola disease (EBOD) and Marburg virus disease (MVD) is critical to provide timely and appropriate care and stop transmission. These...

Disarmament, demobilization and reintegration and mental health and psychosocial support: operational guidance

This operational guidance addresses the integration of mental health and psychosocial support (MHPSS) into disarmament, demobilization and reintegration...

WHO Expert Committee on Biological Standardization: eighty-first report

The eighty-first report of the WHO Expert Committee on Biological Standardization presents the deliberations and recommendations arising from the Committee’s...

Integrated approach to management of skin-related neglected tropical diseases and common skin conditions

Neglected tropical diseases (NTDs) are a diverse group of disease conditions that disproportionately a£ect populations living in poverty, particularly...

An illustration of people of various ages walking together

The Global status report on cancer 2026: the future we choose together provides a comprehensive assessment of the global burden of cancer, progress in...

WHO optimal antiretroviral dosing guidance: recommendations for dosing medicines for HIV prevention and treatment in paediatric populations

This guidance presents updated recommendations on antiretroviral drug dosing for neonates, infants and children, drawing on recent pharmacokinetic evidence,...

Related resources

The ASSIST-linked brief intervention for hazardous and harmful substance use

This manual is a companion to ‘The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care’. The...

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed for the World Health Organization (WHO) by an international group...

Self-help strategies for cutting down or stopping substance use (ASSIST)

Substance use problems can arise as a result of acute intoxication, regular use or dependence - and from the way in which substances are used. This guide...

Guidelines for identification and management of substance use and substance use disorders in pregnancy

These guidelines contain recommendations on the identification and management of substance use and substance use disorders for health care services which...

mhGAP Intervention Guide - Version 2.0

This is the second version (2016) of the mhGAP Intervention Guide (mhGAP-IG) for mental, neurological and substance use (MNS) disorders in non-specialist...

mhGAP Training Manuals - for the mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings, version 2.0

As part of the Mental Health Gap Action Programme, WHO has developed training manuals (Training of trainers and supervisors training manual and Training...

Involvement of nurses and midwives in screening and brief interventions

Psychoactive substance use can result in a wide range of health and social problems for individuals, their families and the wider community. Globally,...